Medical Developments International Limited (ASX:MVP)
Australia · Delayed Price · Currency is AUD 0.4050
-0.0050 (-1.22%)
Oct 19, 2026, 4:10 PM AEST
ASX:MVP Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, ASX:MVP stock has an average price target of $2.30. The average 1-year stock price forecast is 467.90% higher than the current stock price, while the lowest is $1.00 (+146.91%) and the highest is $3.60 (+788.89%).
Price Target: $2.30 (+467.90%)
Analyst Consensus: n/a
Price Target
ChartAnalyst Ratings
According to 1 stock analyst, the rating for ASX:MVP is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bell Potter | Bell Potter | Buy Maintains $1.00 | Buy | Maintains | $1.00 | +146.91% | Oct 15, 2026 |
Financial Forecast
Revenue This Year
45.95M
from 42.57M
Increased by 7.94%
Revenue Next Year
51.30M
from 45.95M
Increased by 11.64%
EPS This Year
0.01
from 0.01
Increased by 135.85%
EPS Next Year
0.04
from 0.01
Increased by 204.00%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.